| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Neoplasms | 31 | 2014 | 587 | 4.160 |
Why?
|
| ErbB Receptors | 10 | 2014 | 513 | 2.210 |
Why?
|
| Colitis | 10 | 2014 | 262 | 1.530 |
Why?
|
| Ursodeoxycholic Acid | 6 | 2010 | 26 | 1.300 |
Why?
|
| Isoenzymes | 17 | 2003 | 278 | 1.180 |
Why?
|
| Protein Kinase C | 21 | 2012 | 265 | 1.160 |
Why?
|
| Azoxymethane | 18 | 2011 | 84 | 1.080 |
Why?
|
| Colon | 23 | 2013 | 540 | 1.040 |
Why?
|
| Receptors, Calcitriol | 7 | 2014 | 131 | 0.950 |
Why?
|
| Cyclooxygenase 2 | 8 | 2010 | 100 | 0.930 |
Why?
|
| Calcitriol | 17 | 2007 | 173 | 0.910 |
Why?
|
| Down-Regulation | 9 | 2013 | 526 | 0.890 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2014 | 463 | 0.710 |
Why?
|
| Colorectal Neoplasms | 9 | 2014 | 1069 | 0.710 |
Why?
|
| Apoptosis | 11 | 2014 | 1756 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2011 | 1347 | 0.670 |
Why?
|
| Genes, ras | 7 | 2008 | 97 | 0.670 |
Why?
|
| Cell Proliferation | 10 | 2014 | 1753 | 0.670 |
Why?
|
| Cyclin D1 | 8 | 2008 | 85 | 0.660 |
Why?
|
| Adenocarcinoma | 7 | 2011 | 1191 | 0.660 |
Why?
|
| Precancerous Conditions | 4 | 2012 | 206 | 0.570 |
Why?
|
| Colitis, Ulcerative | 4 | 2013 | 800 | 0.550 |
Why?
|
| Benzenesulfonates | 2 | 2008 | 50 | 0.540 |
Why?
|
| MicroRNAs | 3 | 2011 | 591 | 0.540 |
Why?
|
| Caco-2 Cells | 13 | 2012 | 125 | 0.540 |
Why?
|
| Paramyxovirinae | 2 | 2008 | 2 | 0.540 |
Why?
|
| Membrane Fusion | 2 | 2008 | 38 | 0.530 |
Why?
|
| beta Catenin | 7 | 2012 | 266 | 0.490 |
Why?
|
| Intestinal Mucosa | 12 | 2014 | 824 | 0.490 |
Why?
|
| Tetradecanoylphorbol Acetate | 9 | 2006 | 128 | 0.480 |
Why?
|
| Dextran Sulfate | 6 | 2013 | 70 | 0.480 |
Why?
|
| Pyridines | 2 | 2008 | 319 | 0.470 |
Why?
|
| Signal Transduction | 15 | 2014 | 3581 | 0.460 |
Why?
|
| Cholecalciferol | 3 | 2007 | 35 | 0.460 |
Why?
|
| Animals | 52 | 2014 | 28901 | 0.450 |
Why?
|
| Rats | 31 | 2012 | 4155 | 0.450 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 33 | 0.430 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2014 | 7 | 0.420 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 84 | 0.420 |
Why?
|
| Panax | 3 | 2014 | 171 | 0.410 |
Why?
|
| Plant Extracts | 2 | 2014 | 248 | 0.400 |
Why?
|
| Barrett Esophagus | 3 | 2012 | 94 | 0.390 |
Why?
|
| G1 Phase | 4 | 2011 | 66 | 0.380 |
Why?
|
| Cell Line, Tumor | 10 | 2014 | 2776 | 0.370 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 37 | 0.360 |
Why?
|
| Esophageal Neoplasms | 3 | 2012 | 345 | 0.360 |
Why?
|
| NF-kappa B | 5 | 2014 | 469 | 0.360 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2012 | 126 | 0.350 |
Why?
|
| Viral Fusion Proteins | 2 | 2008 | 10 | 0.350 |
Why?
|
| Stromal Cells | 1 | 2012 | 151 | 0.350 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 14 | 0.350 |
Why?
|
| Proto-Oncogenes | 1 | 2011 | 61 | 0.340 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2009 | 118 | 0.340 |
Why?
|
| Dietary Fats | 1 | 2011 | 137 | 0.340 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 71 | 0.330 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2011 | 45 | 0.330 |
Why?
|
| Antineoplastic Agents | 4 | 2014 | 2385 | 0.330 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 157 | 0.330 |
Why?
|
| Mice | 19 | 2014 | 12525 | 0.330 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 78 | 0.320 |
Why?
|
| Up-Regulation | 6 | 2013 | 740 | 0.310 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 50 | 0.310 |
Why?
|
| Cell Division | 7 | 2007 | 701 | 0.310 |
Why?
|
| Rats, Inbred F344 | 11 | 2008 | 165 | 0.300 |
Why?
|
| Calcium | 8 | 2012 | 1205 | 0.290 |
Why?
|
| Disease Models, Animal | 9 | 2014 | 2534 | 0.290 |
Why?
|
| Lithocholic Acid | 1 | 2008 | 2 | 0.280 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2014 | 180 | 0.280 |
Why?
|
| Blotting, Western | 7 | 2011 | 796 | 0.280 |
Why?
|
| Diet | 1 | 2011 | 460 | 0.280 |
Why?
|
| Carcinogens | 4 | 2007 | 105 | 0.270 |
Why?
|
| Protein Kinase C-delta | 3 | 2006 | 29 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 224 | 0.260 |
Why?
|
| Transcriptome | 1 | 2013 | 766 | 0.260 |
Why?
|
| Humans | 50 | 2014 | 95992 | 0.250 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2008 | 465 | 0.250 |
Why?
|
| Collagen Type I | 1 | 2006 | 74 | 0.240 |
Why?
|
| Mutation | 9 | 2008 | 4374 | 0.240 |
Why?
|
| Inflammation | 2 | 2012 | 1063 | 0.240 |
Why?
|
| Chemoprevention | 4 | 2010 | 93 | 0.220 |
Why?
|
| Adenoma | 2 | 2007 | 260 | 0.220 |
Why?
|
| Transfection | 5 | 2012 | 908 | 0.220 |
Why?
|
| RNA, Messenger | 7 | 2011 | 2088 | 0.210 |
Why?
|
| Male | 35 | 2013 | 45792 | 0.210 |
Why?
|
| Immunohistochemistry | 6 | 2013 | 1827 | 0.210 |
Why?
|
| Enzyme Activation | 14 | 2014 | 692 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 611 | 0.200 |
Why?
|
| HCT116 Cells | 3 | 2013 | 164 | 0.200 |
Why?
|
| Anticarcinogenic Agents | 5 | 2006 | 71 | 0.200 |
Why?
|
| Case-Control Studies | 3 | 2013 | 1962 | 0.190 |
Why?
|
| Cholagogues and Choleretics | 1 | 2002 | 10 | 0.190 |
Why?
|
| Cadherins | 2 | 2006 | 179 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2011 | 1670 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 9 | 2013 | 3483 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2014 | 1729 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2002 | 446 | 0.170 |
Why?
|
| Food-Processing Industry | 1 | 2001 | 3 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2014 | 2160 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2008 | 152 | 0.170 |
Why?
|
| Food Preferences | 1 | 2001 | 27 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 299 | 0.170 |
Why?
|
| Cells, Cultured | 8 | 2012 | 2928 | 0.170 |
Why?
|
| Ginsenosides | 2 | 2012 | 124 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2011 | 79 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 349 | 0.160 |
Why?
|
| Polyethylene Glycols | 3 | 2008 | 376 | 0.160 |
Why?
|
| Models, Psychological | 1 | 2001 | 166 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 98 | 0.160 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 88 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 367 | 0.160 |
Why?
|
| Adolescent Behavior | 1 | 2001 | 115 | 0.160 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 1191 | 0.150 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 1999 | 118 | 0.150 |
Why?
|
| Environment | 1 | 2001 | 233 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2003 | 1267 | 0.140 |
Why?
|
| Cyclin E | 3 | 2008 | 28 | 0.140 |
Why?
|
| Snail Family Transcription Factors | 3 | 2014 | 48 | 0.140 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 562 | 0.140 |
Why?
|
| Genes, APC | 2 | 2011 | 27 | 0.140 |
Why?
|
| Reference Values | 4 | 2008 | 675 | 0.140 |
Why?
|
| Quinazolines | 3 | 2008 | 216 | 0.140 |
Why?
|
| Niacinamide | 2 | 2008 | 102 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 89 | 0.140 |
Why?
|
| Phenylurea Compounds | 2 | 2008 | 99 | 0.130 |
Why?
|
| Intestinal Neoplasms | 2 | 2011 | 70 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2008 | 35 | 0.130 |
Why?
|
| Mice, Inbred A | 2 | 2007 | 23 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 124 | 0.130 |
Why?
|
| Type C Phospholipases | 1 | 1997 | 27 | 0.130 |
Why?
|
| Intracellular Membranes | 2 | 1994 | 117 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 1997 | 70 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 6 | 2011 | 1046 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 2 | 2014 | 1425 | 0.120 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 83 | 0.120 |
Why?
|
| Tight Junctions | 3 | 2013 | 153 | 0.120 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 269 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2008 | 207 | 0.120 |
Why?
|
| Cyclins | 3 | 2008 | 80 | 0.120 |
Why?
|
| HT29 Cells | 3 | 2014 | 50 | 0.110 |
Why?
|
| Epithelial Cells | 6 | 2013 | 704 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 1966 | 0.110 |
Why?
|
| Cell Differentiation | 7 | 2014 | 1662 | 0.110 |
Why?
|
| Kinetics | 9 | 1999 | 1561 | 0.110 |
Why?
|
| Guanylate Cyclase | 4 | 1994 | 19 | 0.110 |
Why?
|
| Titanium | 1 | 2014 | 27 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 2 | 2008 | 66 | 0.110 |
Why?
|
| Enteritis | 1 | 2014 | 23 | 0.110 |
Why?
|
| Angiotensin II | 1 | 2014 | 95 | 0.110 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 14 | 0.110 |
Why?
|
| Enzyme Inhibitors | 5 | 2006 | 655 | 0.110 |
Why?
|
| Telomere Homeostasis | 1 | 2014 | 30 | 0.100 |
Why?
|
| Disease Progression | 3 | 2012 | 1561 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2008 | 909 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2014 | 92 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2002 | 618 | 0.100 |
Why?
|
| Cholic Acid | 2 | 2008 | 8 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 1880 | 0.090 |
Why?
|
| Bradykinin | 1 | 1992 | 46 | 0.090 |
Why?
|
| DNA, Complementary | 1 | 2013 | 394 | 0.090 |
Why?
|
| Base Sequence | 2 | 2008 | 2341 | 0.090 |
Why?
|
| Estrogen Receptor beta | 1 | 2012 | 26 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 172 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2013 | 477 | 0.090 |
Why?
|
| Peptide Hormones | 1 | 2012 | 30 | 0.090 |
Why?
|
| Female | 9 | 2014 | 49980 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3040 | 0.090 |
Why?
|
| Adipokines | 1 | 2011 | 18 | 0.090 |
Why?
|
| Lectins | 1 | 2011 | 84 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 45 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 376 | 0.080 |
Why?
|
| Phospholipase D | 3 | 1999 | 13 | 0.080 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 36 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2012 | 68 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 620 | 0.080 |
Why?
|
| Cetuximab | 1 | 2011 | 119 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 701 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 312 | 0.080 |
Why?
|
| Butyrates | 1 | 2011 | 58 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2002 | 227 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 139 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 354 | 0.080 |
Why?
|
| Vitamin D | 2 | 2007 | 273 | 0.080 |
Why?
|
| GTP-Binding Proteins | 3 | 1999 | 148 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2011 | 236 | 0.080 |
Why?
|
| Phosphatidylcholines | 2 | 1999 | 50 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2012 | 477 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1533 | 0.080 |
Why?
|
| Dietary Supplements | 2 | 2008 | 133 | 0.080 |
Why?
|
| Phosphorylation | 5 | 2012 | 1156 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2013 | 647 | 0.080 |
Why?
|
| Splints | 1 | 1989 | 10 | 0.080 |
Why?
|
| Finger Injuries | 1 | 1989 | 12 | 0.080 |
Why?
|
| Carcinoma | 1 | 2012 | 444 | 0.070 |
Why?
|
| HN Protein | 1 | 2008 | 4 | 0.070 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1989 | 41 | 0.070 |
Why?
|
| Tendon Injuries | 1 | 1989 | 39 | 0.070 |
Why?
|
| Point Mutation | 1 | 2009 | 247 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 100 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 200 | 0.070 |
Why?
|
| Vero Cells | 1 | 2008 | 106 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2006 | 25 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2006 | 17 | 0.070 |
Why?
|
| Cyclin D | 1 | 2008 | 15 | 0.070 |
Why?
|
| Microvilli | 1 | 1988 | 44 | 0.070 |
Why?
|
| Middle Aged | 5 | 2013 | 28299 | 0.070 |
Why?
|
| Ligands | 1 | 2009 | 478 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2012 | 1376 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 396 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 1988 | 131 | 0.070 |
Why?
|
| Clone Cells | 1 | 2008 | 223 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 983 | 0.070 |
Why?
|
| DNA Primers | 1 | 2008 | 548 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 458 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2008 | 522 | 0.070 |
Why?
|
| Bacteria | 1 | 2011 | 516 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 1309 | 0.070 |
Why?
|
| Pancreas | 1 | 1989 | 263 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 1997 | 25 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2009 | 381 | 0.060 |
Why?
|
| Kidney | 1 | 1992 | 1135 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 750 | 0.060 |
Why?
|
| Probability | 1 | 2008 | 365 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 579 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 398 | 0.060 |
Why?
|
| Cell Line | 3 | 2009 | 2536 | 0.060 |
Why?
|
| Intestine, Small | 1 | 1988 | 310 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 56 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 206 | 0.060 |
Why?
|
| Cholesterol | 1 | 1988 | 367 | 0.060 |
Why?
|
| Hypertension | 1 | 1992 | 775 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 85 | 0.060 |
Why?
|
| Viral Plaque Assay | 1 | 2006 | 19 | 0.060 |
Why?
|
| Models, Biological | 3 | 2008 | 1810 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2006 | 39 | 0.060 |
Why?
|
| Giant Cells | 1 | 2006 | 19 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 935 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 1079 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2006 | 61 | 0.060 |
Why?
|
| Time Factors | 4 | 2009 | 5593 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 873 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 301 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 223 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 1021 | 0.060 |
Why?
|
| Gene Expression | 2 | 2002 | 1319 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2090 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 430 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2006 | 162 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2014 | 712 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 509 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 358 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2006 | 289 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1191 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 62 | 0.050 |
Why?
|
| Virus Replication | 1 | 2006 | 326 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2000 | 684 | 0.050 |
Why?
|
| Swine | 1 | 2006 | 607 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2010 | 9228 | 0.050 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Activin Receptors, Type I | 1 | 2002 | 13 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 103 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2003 | 97 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2002 | 52 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2002 | 67 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 103 | 0.050 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 3 | 1997 | 7 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 321 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 202 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2002 | 89 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 231 | 0.050 |
Why?
|
| Food, Organic | 1 | 2001 | 3 | 0.040 |
Why?
|
| Psychology, Social | 1 | 2001 | 9 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2000 | 7 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 44 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 930 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 147 | 0.040 |
Why?
|
| Membrane Proteins | 3 | 2010 | 1275 | 0.040 |
Why?
|
| Phosphoinositide Phospholipase C | 2 | 1997 | 6 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1999 | 10 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1998 | 1014 | 0.040 |
Why?
|
| Guanine | 1 | 1999 | 207 | 0.040 |
Why?
|
| Protein Kinase C-alpha | 4 | 1999 | 29 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 7034 | 0.040 |
Why?
|
| Caspases | 2 | 2012 | 156 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 2042 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3642 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 412 | 0.030 |
Why?
|
| Incidence | 1 | 2002 | 1723 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1642 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 1997 | 14 | 0.030 |
Why?
|
| Tyrosine | 1 | 1997 | 132 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1998 | 687 | 0.030 |
Why?
|
| Neoplasms | 1 | 2012 | 3242 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2012 | 87 | 0.030 |
Why?
|
| Cholic Acids | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cell Movement | 2 | 2011 | 816 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 897 | 0.030 |
Why?
|
| Piroxicam | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 156 | 0.030 |
Why?
|
| Intestines | 1 | 1998 | 432 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 1994 | 8 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1994 | 28 | 0.030 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1994 | 2 | 0.030 |
Why?
|
| Zanthoxylum | 1 | 2014 | 9 | 0.030 |
Why?
|
| Zingiberaceae | 1 | 2014 | 10 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 181 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 48 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2014 | 35 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 84 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1994 | 297 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 80 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2014 | 136 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 1995 | 107 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2014 | 88 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1995 | 216 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 69 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2013 | 16 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2014 | 81 | 0.030 |
Why?
|
| Microsomes | 1 | 1993 | 35 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2011 | 686 | 0.020 |
Why?
|
| Thumb | 1 | 1993 | 27 | 0.020 |
Why?
|
| Adult | 2 | 2011 | 28636 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 1992 | 9 | 0.020 |
Why?
|
| Vinblastine | 1 | 1992 | 85 | 0.020 |
Why?
|
| Daunorubicin | 1 | 1992 | 78 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2001 | 2860 | 0.020 |
Why?
|
| Evans Blue | 1 | 1992 | 4 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1992 | 33 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 1992 | 31 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 204 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Arteries | 1 | 1993 | 181 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 1982 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2012 | 25 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 303 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 69 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2012 | 46 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1992 | 235 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 89 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2012 | 32 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 70 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1992 | 121 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 547 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2012 | 154 | 0.020 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 165 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 516 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1992 | 285 | 0.020 |
Why?
|
| Maleimides | 2 | 2003 | 27 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 88 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2012 | 110 | 0.020 |
Why?
|
| Estradiol | 1 | 2012 | 255 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 127 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 671 | 0.020 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2011 | 46 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 297 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 183 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 281 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 476 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1992 | 454 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 462 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 516 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 205 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 311 | 0.020 |
Why?
|
| Traction | 1 | 1989 | 8 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 340 | 0.020 |
Why?
|
| Indoles | 2 | 2003 | 317 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1989 | 33 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1167 | 0.020 |
Why?
|
| Protein Kinase C beta | 2 | 1999 | 13 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2010 | 255 | 0.020 |
Why?
|
| Proteins | 1 | 2014 | 816 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1329 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1989 | 279 | 0.020 |
Why?
|
| Myosins | 1 | 1989 | 94 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 281 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 311 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1988 | 41 | 0.020 |
Why?
|
| Liposomes | 1 | 1988 | 101 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1560 | 0.020 |
Why?
|
| Adolescent | 1 | 2001 | 9878 | 0.020 |
Why?
|
| Equipment Design | 1 | 1989 | 435 | 0.020 |
Why?
|
| Liver | 1 | 1992 | 1231 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1989 | 239 | 0.020 |
Why?
|
| Ulcer | 1 | 2007 | 38 | 0.020 |
Why?
|
| Lysosomes | 1 | 2008 | 124 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 144 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 1158 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2007 | 117 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 466 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 385 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 2059 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 1998 | 368 | 0.010 |
Why?
|
| Wound Healing | 1 | 2007 | 378 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2008 | 447 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 1097 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1988 | 682 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 871 | 0.010 |
Why?
|
| Enterotoxins | 2 | 1994 | 22 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 124 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 164 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 790 | 0.010 |
Why?
|
| Bacterial Toxins | 2 | 1994 | 115 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 1319 | 0.010 |
Why?
|
| Escherichia coli Proteins | 2 | 1994 | 190 | 0.010 |
Why?
|
| Water | 1 | 2004 | 307 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1994 | 329 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 65 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 36 | 0.010 |
Why?
|
| Zinc | 1 | 2001 | 101 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2000 | 33 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 29 | 0.010 |
Why?
|
| Curcumin | 1 | 1999 | 16 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 33 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 68 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 76 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 187 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 113 | 0.010 |
Why?
|
| Ionomycin | 1 | 1999 | 21 | 0.010 |
Why?
|
| Carbazoles | 1 | 1999 | 31 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1999 | 16 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 603 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 1999 | 88 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 1029 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 1006 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1995 | 13 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1995 | 10 | 0.010 |
Why?
|
| Ethers, Cyclic | 1 | 1995 | 8 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 50 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 58 | 0.010 |
Why?
|
| Estrenes | 1 | 1994 | 8 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 329 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1994 | 16 | 0.010 |
Why?
|
| Terpenes | 1 | 1994 | 18 | 0.010 |
Why?
|
| Natriuretic Peptides | 1 | 1994 | 7 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1994 | 55 | 0.010 |
Why?
|
| Staurosporine | 1 | 1994 | 34 | 0.010 |
Why?
|
| Alkaloids | 1 | 1994 | 47 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1989 | 10307 | 0.010 |
Why?
|
| Pirenzepine | 1 | 1994 | 8 | 0.010 |
Why?
|
| Diamines | 1 | 1994 | 11 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1994 | 19 | 0.010 |
Why?
|
| Atropine | 1 | 1994 | 61 | 0.010 |
Why?
|
| ras Proteins | 1 | 1995 | 134 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1994 | 82 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1994 | 61 | 0.010 |
Why?
|
| Alamethicin | 1 | 1993 | 1 | 0.010 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1993 | 11 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1993 | 14 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1993 | 21 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1993 | 39 | 0.010 |
Why?
|
| Stearates | 1 | 1992 | 1 | 0.010 |
Why?
|
| Benzyl Alcohols | 1 | 1992 | 2 | 0.010 |
Why?
|
| Benzyl Alcohol | 1 | 1992 | 3 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1993 | 63 | 0.010 |
Why?
|
| Piperidines | 1 | 1994 | 171 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1993 | 77 | 0.010 |
Why?
|
| Microsurgery | 1 | 1993 | 99 | 0.010 |
Why?
|
| Biological Transport | 1 | 1992 | 412 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 20927 | 0.000 |
Why?
|